FreeThink Technologies develops products and solves complex problems related to pharmaceutical stability and formulation using scientific methods.

FreeThink Technologies

FreeThink Technologies, Inc. | 1,525 followers on LinkedIn. Using world-class science to speed better products to market. | FreeThink Technologies is a science-based company that conducts experimental work to help clients develop drug products. FreeThink has specific expertise in stability (shelf life) and complex formulation development. FreeThink scientists are experts at developing stability-indicating methods, determining shelf lives, developing formulations for complex needs, and determining packaging.

Mark Kastan

Chief Science Officer at FreeThink Technologies, Inc

Alisa Waterman

Quality Assurance at FreeThink Technologies, Inc.

Thomas Morison

President and Founder at FreeThink Technologies, Inc

Ken Waterman, Ph.D.

FreeThink Technologies, Inc.

Dave Lucey and John Shen are in Chicago talking #stability ! Visit the FreeThink Technologies, Inc. booth W-13074 in the #PackExpo healthcare pavilion. #packaging #shelflife #pharma #productdevelopment

Visit our website to apply {{ https://lnkd.in/gB_esJSG}}

Day two at #PODD2024 Dave Lucey is joined by FreeThink Technologies, Inc. Project Coordinator, John Shen ! Day one featured a compelling talk by our president Ken Waterman, Ph.D. : OzmoCAP®, a New Osmotic, Controlled Release Capsule. #drugdelivery #pharma #controlledrelease #researchanddevelopment

This event is co-sponsored by FreeThink Technologies, Inc. and Lhasa Limited . For more information and to register visit {{ https://lnkd.in/eEdbfYmy}}

Please join us at #PODD2024 in Boston and participate in the Technical Talk by FreeThink Technologies, Inc. ’s president, Ken Waterman, Ph.D. : OzmoCAP®, a new osmotic, controlled release capsule -OzmoCAP® technology allows for a rapid, material-sparing assessment of oral, controlled-release drug delivery. -The technology provides a universal platform for zero-order metered release of drugs with excellent in vitro–in vivo correlation (IVIVC). -OzmoCAP® combined with contrast agents enables imaging to correlate the dosage form position in the gastrointestinal tract with pharmacokinetics. #pharmaceutical #drugdelivery #formulationdevelopment

Will we see you in Salt Lake City? Our team is heading to AAPS PharmSci360 from October 20-23, 2024, and we can't wait to connect with you! Join us at booth 2602 at the Salt Palace Convention Center for the latest in pharmaceutical science and innovation. Whether you're looking to learn more about our services or network with industry experts, this is your chance! Don’t miss out—book an appointment with us today (mailto: david.lucey@freethinktech.com ) and let's discuss how we can support your formulation and stability needs. 👉 Register for AAPS PharmSci360 https://www.aaps.org/home #FreeThinkTechnologies #PharmSci360 #AAPS

We’re #hiring a new Formulation Scientist/Engineer in Branford, Connecticut. Apply today or share this post with your network.

FreeThink will be participating in the following events this fall: AAPS Pharm Sci 360, Salt Lake City, UT – October 20-23, 2024 PODD Partnership Opportunities in Drug Delivery, Boston, MA – October 28-29, 2024 Technical Talk by Ken Waterman, Ph.D. : OzmoCAP®, a new osmotic, controlled release capsule OzmoCAP® technology allows for a rapid, material-sparing assessment of oral, controlled-release drug delivery. The technology provides a universal platform for zero-order metered release of drugs with excellent in vitro-in vivo correlation (IVIVC). OzmoCAP® combined with contrast agents enables imaging to correlate the dosage form position in the gastrointestinal tract with pharmacokinetics. Pack Expo International, Chicago, IL – November 3-6, 2024 We hope to see you, and if you’d like to meet during any of the events, please contact Dave Lucey . #pharmsci360 #PODD #packexpo #stability #drugdelivery #packaging

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 10:33 AM	635b6fd3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 10:33 AM	abe39b50
crunchbase trigger	general	Nov 12, 2024 10:33 AM	d361d0e2
crunchbase profile	general
li profile	general	Nov 12, 2024 10:33 AM	2cd76aea
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 10:33 AM	85be8603
news basic	general	Nov 12, 2024 10:33 AM	47f6de1c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

FREE

COM:FREETHINKTECH

FreeThink Technologies